EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Change of erythrocyte sedimentation rate as prognostic biomarker for Mycobacterium avium complex pulmonary disease through anti-mycobacterial treatment

Hyeontaek Hwang, Joong-Yub Kim, Jae-Joon Yim, Nakwon Kwak iD

Therapeutic Advances in Respiratory Disease · 2024-01 · 18

DOI: 10.1177/17534666241282272 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Advances in Respiratory Disease, online erschienen am 23.09.2024. Verfasst von Hyeontaek Hwang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of …. Hauptthemen laut MEDLINE: Biomarkers, Blood Sedimentation, Mycobacterium avium, Tuberculosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

It remains unclear whether erythrocyte sedimentation rate (ESR) accurately predicts prognosis during treatment and how ESR changes.

Objectives

We aimed to assess the predictive values of ESR as a prognostic factor of Mycobacterium avium complex pulmonary disease (MAC-PD) while on anti-mycobacterial treatment and its changes according to the treatment responses.

Design

This study is a retrospective cohort study.

Methods

This study included patients aged 18 years or older who initiated anti-mycobacterial treatment for MAC-PD at Seoul National University Hospital between January 1, 2009 and March 31, 2022. ESR should be measured at least twice, with a minimum interval of 3 months, during the initial 12 months from the commencement of antibiotic treatment. A mixed linear regression and Cox proportional-hazards models were used to analyze repeated ESR data and the association with patient survival.

Results

Of a total of 825 patients who initiated antibiotic treatment for MAC-PD, 369 patients were included in the analysis. Increased levels of ESR during the treatment process were associated with a higher risk of mortality (adjusted hazard ratio 1.03; 95% confidence interval, 1.02–1.03) after adjusting age, sex, comorbidities, presence of cavity, acid-fast bacilli smear positivity, and culture conversion at 12 months. During the treatment, ESR at 12 months of treatment significantly decreased compared to baseline ESR in both the culture-converted and not-converted groups, which was categorized based on whether the culture conversion was achieved within the 12 months after treatment initiation.

Conclusion

ESR predicted mortality during treatment and decreased over time, regardless of treatment outcomes. Our results underscore the importance of administering anti-mycobacterial treatment even in patients who did not achieve a microbiological cure.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiomarkersBlood SedimentationMycobacterium aviumTuberculosisPrognosisRetrospective StudiesCohort StudiesHumansMaleFemaleMiddle AgedAgedAnti-Bacterial AgentsKaplan-Meier Estimate

Stichwörter der Autor:innen

Mycobacterium aviumbiomarkerserythrocyte sedimentation rateprognosis

Substanzen

BiomarkersAnti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea Department of Internal Medicine, Seoul National University Colle…
  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul National University College of Medicine/Seoul National University Hospital, 101 Daehak-ro, Jongno-gu, Seoul 110-744, South Korea.

ORCID-Profile: Nakwon Kwak

Zitieren

APA

Hwang, H., Kim, J. Y., Yim, J. J., & Kwak, N. (2024). Change of erythrocyte sedimentation rate as prognostic biomarker for Mycobacterium avium complex pulmonary disease through anti-mycobacterial treatment. Therapeutic Advances in Respiratory Disease, 18. https://doi.org/10.1177/17534666241282272

Vancouver

Hwang H, Kim JY, Yim JJ, Kwak N. Change of erythrocyte sedimentation rate as prognostic biomarker for Mycobacterium avium complex pulmonary disease through anti-mycobacterial treatment. Therapeutic Advances in Respiratory Disease. 2024;18. doi:10.1177/17534666241282272

BibTeX
@article{Hwang2024,
  author = {Hwang, Hyeontaek and Kim, Joong-Yub and Yim, Jae-Joon and Kwak, Nakwon},
  title = {Change of erythrocyte sedimentation rate as prognostic biomarker for Mycobacterium avium complex pulmonary disease through anti-mycobacterial treatment},
  journal = {Therapeutic Advances in Respiratory Disease},
  year = {2024},
  volume = {18},
  doi = {10.1177/17534666241282272}
}
Kostenlos starten →